China is treating tens of thousands of its citizens with experimental coronavirus vaccines that have not had completed standard testing — raising concerns about safety.
In July, China launched a vaccine emergency use program offering three experimental shots developed by a unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and biopharmaceutical company Sinovac Biotech.
The vaccines were aimed to protect essential workers, including those in the medical field, transportation industry and grocery store workers.
But now, China National Biotec Group — the Sinopharm unit developing two of the emergency use vaccines — and Sinovac Biotech have confirmed that at least tens of thousands of people have been jabbed with the untested inoculations.
Among those who received an early shot was the chief biosafety expert for the country’s Center for Disease Control and Prevention.
“So far, among the people who were vaccinated, no one has been sick with the disease,” Guizhen Wu said on state TV this week, while also revealing she had received a vaccination in April.
“So far, [the vaccination scheme] works very well. No side effect occurred.”
A fourth COVID-19 vaccine being developed by CanSino Biologics was also approved for use by the Chinese military in June.
White House economic adviser Larry Kudlow on Wednesday said the…